EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Have we overlooked the role of mifepristone for the medical management of tubal ectopic pregnancy?

Julia Oltman, Sanjana Balachander, Ben W Mol iD, Andrea M F Woolner iD

Human Reproduction · 2023

DOI: 10.1093/humrep/dead116 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, 2023. Verfasst von Julia Oltman und 3 weiteren Autor:innen. Beteiligte Einrichtung: Aberdeen Centre for Women's Health Research, Institute of Applied Health Sciences, School of Medicine, Medical Sciences and Nutrition, University of …. Hauptthemen laut MEDLINE: Pregnancy, Tubal, Pregnancy, Ectopic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHMRC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ectopic pregnancy is a risk of both spontaneous and assisted reproduction pregnancies. The majority of ectopic pregnancies abnormally implant within a fallopian tube (extrauterine pregnancies). In haemodynamically stable women, medical or expectant treatment can be offered. Currently accepted medical treatment is using a drug called methotrexate. However, methotrexate has potential adverse effects, and a significant proportion of women will still require emergency surgery (up to 30%) to remove the ectopic pregnancy. Mifepristone (RU-486) has anti-progesterone effects and has a role in managing intrauterine pregnancy loss and termination of pregnancy. On reviewing the literature and given progesterone’s pivotal role in sustaining pregnancy, we propose that we may have overlooked the role of mifepristone in the medical management of tubal ectopic pregnancy in haemodynamically stable women.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pregnancy, TubalPregnancy, EctopicPregnancyFemaleHumansMifepristoneMethotrexateFallopian Tubes

Stichwörter der Autor:innen

RU148ectopic pregnancyfallopian tubemethotrexatemifepristone

Substanzen

MifepristoneMethotrexate

Autor:innen und Institutionen

  • Aberdeen Centre for Women's Health Research, Institute of Applied Health Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK.
  • School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
  • Monash Medical Centre Clayton, Obstetrics and Gynaecology, Monash Medical Centre, Clayton, Victoria, Australia.
  • Monash University, Clayton, Victoria, Australia.

ORCID-Profile: Ben W Mol, Andrea M F Woolner

Förderung

  • NHMRC

Zitieren

APA

Oltman, J., Balachander, S., Mol, B. W., & Woolner, A. M. F. (2023). Have we overlooked the role of mifepristone for the medical management of tubal ectopic pregnancy?. Human Reproduction. https://doi.org/10.1093/humrep/dead116

Vancouver

Oltman J, Balachander S, Mol BW, Woolner AMF. Have we overlooked the role of mifepristone for the medical management of tubal ectopic pregnancy?. Human Reproduction. 2023. doi:10.1093/humrep/dead116

BibTeX
@article{Oltman2023,
  author = {Oltman, Julia and Balachander, Sanjana and Mol, Ben W and Woolner, Andrea M F},
  title = {Have we overlooked the role of mifepristone for the medical management of tubal ectopic pregnancy?},
  journal = {Human Reproduction},
  year = {2023},
  doi = {10.1093/humrep/dead116}
}
Kostenlos starten →